Login / Register The Most Trusted Name in Medical Education


From breast cancer to myeloma and gastric cancer, Elsevier's Office of Continuing Medical Education offers complimentary CME courses for a variety of oncology subject matters.

Thumbnail 116x140 LearningCenter v2

Progress in Pancreatic Cancer

Format: Resource Center

Welcome to the Progress in Pancreatic Cancer Learning Center. This Learning Center is a freely accessible, educational platform for healthcare providers who treat patients with pancreatic cancer

Our goal is to ensure that you – the practicing clinician – have access to the most accurate, up-to-date information for the treatment of patients with pancreatic cancer. Within this learning center, you will have access to complimentary continuing medical education (CME) activities highlighting up-to-the-minute emerging evidence that can be applied to everyday practice. Additional resources include open access to the full text of relevant peer-reviewed articles, clinical guidelines, interactive infographics, and other materials dedicated to helping you improve patient care.

As new data emerge, we will be updating the Progress in Pancreatic Cancer Learning Center with new CME activities and timely materials, so please check back often for the latest offerings.

We know you will find these resources helpful in your clinical practice, and hope that you will make the Progress in Pancreatic Cancer Learning Center your destination for pancreatic cancer education.

Take Course »

Credits: 0.75 AMA PRA Category 1 Credit™ per module

Management of Patients with Relapsed/Refractory Multiple Myeloma: Elsevier CME Independent Conference Highlights from EBMT and EHA 2018

Format: Conference Reporter

*This webcast is not endorsed by the conference organizer. The Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference-coverage educational programs.

In this CME-accredited webcast, three experts discuss the clinical implications of some of the latest important research on relapsed/refractory multiple myeloma (RRMM). The roundtable discussion covers new data presented at the 2018 annual meetings of the European Hematology Association (EHA) and the European Society for Blood and Marrow Transplantation (EBMT). The topics discussed include: unmet needs in the treatment of RRMM; new data on treatment strategies (including the roles of proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies); and emerging treatments, such as chimeric antigen receptor (CAR) T-cell therapies. 

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
Elsevier Website Pleural Web 116x140 p2 thumbnail

Learning Center Progress in Pleural Mesothelioma

Format: Resource Center

Welcome to Progress in Pleural Mesothelioma, an Elsevier Learning Center. The aim of this learning center is to increase clinical knowledge by providing continuing medical education (CME) activities, research articles, and resources for health care professionals (HCPs) who treat patients with pleural mesothelioma.

Take Course »

Credits: 0.5 AMA PRA Category 1 Credit™